Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea.

Saved in:
Bibliographic Details
Title: Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea.
Authors: Saslow SB; Gastroenterology Research Unit, Mayo Clinic, Rochester, Minnesota 55905, USA., Scolapio JS, Camilleri M, Forstrom LA, Thomforde GM, Burton DD, Rubin J, Pitot HC, Zinsmeister AR
Source: Gut [Gut] 1998 May; Vol. 42 (5), pp. 628-34.
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Print Cited Medium: Print ISSN: 0017-5749 (Print) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0017-5749
DOI:10.1136/gut.42.5.628